Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Time Frame
Facet Toggle
Nov
20
2023
HYBRID
Washington, DC
9:30—11:00 AM ET / 2:30-4:00 PM GMT
November 06, 2023
In this seminar, a team of researchers at CGD and others will present new analysis of USAID's evaluation portfolio, quantifying the impacts on pupils' reading outcomes and examining the cost-effectiveness of American aid. The presentation will be followed by a discussion of policy implications and b...
Nov
15
2023
HYBRID
Washington, DC
10:00—11:30 AM ET / 3:00-4:30 PM GMT
October 31, 2023
For as long as US foreign aid has enjoyed bipartisan support on Capitol Hill, lawmakers have sought to ensure this assistance is transparent, accountable, and effective. Thanks, in part, to passage of the Foreign Aid Transparency and Accountability Act (FATAA) in 2016, US agencies involved in implem...
Oct
9
2019
12:00—1:30 PM
October 01, 2019
Public health programs such antiretroviral therapy (ART) for HIV are likely to have positive spillover benefits to community members beyond the targeted beneficiaries that could be many times larger than the direct benefits. Join CGD for a brownbag seminar to discuss Dr. Zoë McLaren’s rec...
Oct
3
2019
4:00—5:30 PM
July 10, 2019
Global trade is facing strong political headwinds in the United States. While evidence shows trade generally yields economic benefits on balance, gains are distributed unevenly. Trade agreements are also negotiated in secret and increasingly address regulatory issues in ways that raise concerns amon...
Jun
13
2018
9:30—11:00 AM
May 30, 2018
In outlining his vision for U.S. development assistance, US Agency for International Development (USAID) Administrator Mark Green has emphasized fidelity to an overarching purpose—ending its need to exist. Consistent with this objective, USAID has been developing a new strategic approach that ...
Aug
10
2017
12:30—2:00 PM
July 31, 2017
The 2014-2015 Ebola epidemic broke out and affected thousands of people at a time when there were no medicines approved to treat or prevent Ebola. Poor infrastructure, capacity gaps, widespread mistrust, and disagreements over the design and ethical nature of any clinical trials complicated efforts ...
Jun
28
2016
12:30—2:00 PM
June 17, 2016
Join us for a seminar with economist Markus Haacker, who will discuss the motivations behind and findings from his forthcoming book, The Economics of the Global Response to HIV/AIDS. As in the book, Haacker will review the global impact of and response to HIV/AIDS to date. He will also address ...
Feb
23
2016
3:30—4:30 PM
February 19, 2016
The Institute for Disease Modeling conducts quantitative research aimed at disease eradication through the application of tools such as statistical and individual-based modeling. This talk will provide an overview of the Institute, and then focus on several vignettes that highlight how modelin...
Oct
8
2015
2:30—4:00 PM
October 06, 2015
Global financial resources for health have substantially increased over the period of the MDGs but are now steady or declining. Domestic resources in low- and middle-income countries may not be able to keep up with demand for treatment needs, let alone other prevention services. In this context, the...
Sep
29
2015
12:30—2:00 PM
September 22, 2015
The world recently reached a milestone in the fight against HIV/AIDS: 15 million people around the globe now have access to life-saving antiretroviral therapy (ART). In 2001, only 1 million people had such access. This has resulted in tremendous gains in population health and life expectancy for HIV...